The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
出版年: | BMC Anesthesiology 22(2022)S. 12 |
---|---|
主要な著者: | Unterberg, Matthias (著者), Rahmel, Tim (著者), Köhler, Thomas (著者), Henzler, Dietrich (著者), Schwier, Elke (著者) |
フォーマット: | 論文 |
言語: | English |
出版事項: |
2022
|
主題: | |
オンライン・アクセス: | https://doi.org/10.1186/s12871-021-01547-8 |
関連資料: | In:
BMC Anesthesiology |
類似資料
-
Dosing of Antimycotic Treatment in Sepsis-Induced Liver Dysfunction by Functional Liver Testing with LiMAx
著者:: Kirchner, Carmen, 等
出版事項: (2019) -
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
著者:: Köhler, Thomas, 等
出版事項: (2021) -
Interrupted Chain of Transmission in a Pediatric COVID-19 Case
著者:: Grautoff, Steffen
出版事項: (2020) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
著者:: Köhler, Thomas, 等
出版事項: (2022) -
Profound decrease of liver maximum function capacity test of isoflurane sedated patients : a report of three cases
著者:: Schwier, Elke, 等
出版事項: (2021)